Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
Neuroimage
|
August 17, 2001
Statistical analysis of hippocampal asymmetry in schizophrenia
L Wang, S C Joshi, M I Miller, et al.
Psychiatry Research
|
March 1, 1990
Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia
J W Newcomer, W O Faustman, W Yeh, et al.
Psychiatry Research
|
March 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia
J W Newcomer, S J Riney, S Vinogradov, et al.
Biological Psychiatry
|
April 1, 1986
Oscillations in apomorphine-induced stereotypies during 1 year of apomorphine administration
J G Csernansky, C A Csernansky, R King, et al.
Pharmacology, Biochemistry, and Behavior
|
August 1, 1990
Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants
D E Barnes, B Robinson, J G Csernansky, et al.
Psychopharmacology
|
January 1, 1983
Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients
J G Csernansky, J Kaplan, C A Holman, et al.
Epilepsia
|
May 1, 1990
Psychopathology and limbic epilepsy: relationship to seizure variables and neuropsychological function
J G Csernansky, D B Leiderman, M Mandabach, et al.
Psychiatry Research
|
March 1, 1988
Effects of verapamil administration on negative symptoms of chronic schizophrenia
S B Uhr, K Jackson, P A Berger, et al.
Life Sciences
|
January 1, 1990
Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration
J G Csernansky, D E Barnes, E P Bellows, et al.
Psychopharmacology Bulletin
|
January 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease
J W Newcomer, S J Riney, S Vinogradov, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
Neuroimage
|
August 17, 2001
Statistical analysis of hippocampal asymmetry in schizophrenia
L Wang, S C Joshi, M I Miller, et al.
Psychiatry Research
|
March 1, 1990
Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia
J W Newcomer, W O Faustman, W Yeh, et al.
Psychiatry Research
|
March 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia
J W Newcomer, S J Riney, S Vinogradov, et al.
Biological Psychiatry
|
April 1, 1986
Oscillations in apomorphine-induced stereotypies during 1 year of apomorphine administration
J G Csernansky, C A Csernansky, R King, et al.
Pharmacology, Biochemistry, and Behavior
|
August 1, 1990
Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants
D E Barnes, B Robinson, J G Csernansky, et al.
Psychopharmacology
|
January 1, 1983
Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients
J G Csernansky, J Kaplan, C A Holman, et al.
Epilepsia
|
May 1, 1990
Psychopathology and limbic epilepsy: relationship to seizure variables and neuropsychological function
J G Csernansky, D B Leiderman, M Mandabach, et al.
Psychiatry Research
|
March 1, 1988
Effects of verapamil administration on negative symptoms of chronic schizophrenia
S B Uhr, K Jackson, P A Berger, et al.
Life Sciences
|
January 1, 1990
Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration
J G Csernansky, D E Barnes, E P Bellows, et al.
Psychopharmacology Bulletin
|
January 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease
J W Newcomer, S J Riney, S Vinogradov, et al.
Page
of 14